METTL3 and cancer: Pan-cancer analyses indicate that METTL3 expression correlates with immune cell infiltration, tumor mutation burden, microsatellite instability, mismatch repair gene expression, and epithelial-mesenchymal transition, underscoring its broad impact on both tumor progression and immune modulation.